Guggenheim Capital’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,531
Closed -$116K 1867
2023
Q1
$116K Buy
10,531
+234
+2% +$2.57K ﹤0.01% 1866
2022
Q4
$152K Sell
10,297
-1,598
-13% -$23.7K ﹤0.01% 1838
2022
Q3
$228K Sell
11,895
-121
-1% -$2.32K ﹤0.01% 1748
2022
Q2
$256K Sell
12,016
-250
-2% -$5.33K ﹤0.01% 1845
2022
Q1
$236K Buy
12,266
+1,544
+14% +$29.7K ﹤0.01% 1978
2021
Q4
$222K Buy
+10,722
New +$222K ﹤0.01% 1995